VISICORT PIs Professors Malcolm Walkinshaw (University of Edinburgh) and Conor Murphy (RCSI, Royal College of Surgeons in Ireland) and Dr Karl Burgess and Lisa Imrie were recently awarded funding (£66,500) from the National Eye Research Centre (U.K.), (NERC) for the research project: A Multi-omics approach to eye tissue characterisation in Keratoconus & Fuch’s Dystrophy patients. […]
This author has yet to write their bio.Meanwhile lets just say that we are proud visicort_admin contributed a whooping 98 entries.
Entries by visicort_admin
Sophie Brouard: finding industrial applications for innovations against graft rejection Since 2011, the CNRS (French National Centre for Scientific Research) Innovation Medal rewards figures whose exceptional research work has led to groundbreaking innovation in the technological, economic, therapeutic, and social fields. Our PI Professor Sophie Brouard, of INSERM was one of four 2020 recipients. The […]
We feature several Related Projects on our website. ANIRIDIA.NET is the latest EU-funded project we feature. We caught up with Juliana Martínez-Atienza for a short interview to learn more about this COST Action. My name is Juliana Martínez-Atienza, I am a pharmacist and work as a project manager for the Andalusian Network for Advanced Therapies, […]
Congratulations to the National University of Ireland Galway and Orbsen Therapeutics team of Kevin Lynch, Oliver Treacy, Xizhe Chen, Nick Murphy, Paul Lohan, Md Nahidul Islam, Ellen Donohoe, Matthew D. Griffin, Luke Watson, Steven McLoughlin, Grace O’Malley, Aideen E. Ryan and Thomas Ritter! Their paper: TGF-b1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal […]
VISICORT results were presented at EU-MSC2, a bi-annual event, organized by the Leiden University Medical Center in The Netherlands. The meeting assembles researchers, clinicians and cell product developers working within EU-sponsored research consortia, that focus on mesenchymal stromal cell (MSC) therapy for immune-related disorders and tissue regeneration. EU-MSC2, a much-anticipated event provides excellent opportunities for networking, […]
Thank you for your interest in our research project and the VISICORT results. Our international consortium is fully aware that the current situation regarding the Coronavirus disease (COVID-19) is having a significant impact on the research and innovation community. We anticipate that the precise nature of these impacts may evolve over the coming weeks and months. […]
VISICORT Coordinator Prof Matthew Griffin of the National University of Ireland Galway has recently published three papers acknowledging VISICORT work and funding: Fazekas B and Griffin MD. “Mesenchymal stromal cell-based therapies for acute kidney injury: Progress in the last decade”, Kidney International, In Press, 2020 (Review). 28 January 2020. DOI: https://doi.org/10.1016/j.kint.2019.12.019 Pre-proof available here. Swaminathan […]
The team of Tomás Patrick Griffin, Md Nahidul Islam, Deirdre Wall, John Ferguson, Damian Gerard Griffin, Matthew Dallas Griffin and Paula M. O’Shea from NUI Galway recently published “Plasma dephosphorylated uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential” in the December 2019 edition of the open-access journal Scientific […]
On December 5, 2019, the VISICORT consortium under the leadership of Prof Matthew Griffin at the National University of Ireland Galway met for its final plenary meeting. In Amsterdam for convenience, the partners assembled to share research updates and the progress of the cell manufacturing and clinical trial and to federate its Memorandum of Understanding […]
Prof Dr Uwe Pleyer of Charité Universitätsmedizin Berlin moderated two sessions at the International Ocular Inflammation Society (IOIS) meeting 2019 in Kaohsiung, Taiwan: “Immunology of Cornea/Sclera– update in diagnosis and therapy” and the “Minimum Clinical Datasets in Uveitis – What is this and do we need it?” The meeting took place on November 13- 16, […]
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602470. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.